Please Wait a Moment
X

Articles

06Jul

FDA Releases Zika Virus (ZIKV) Guidance and Grifols ZIKV Assay Licensed

06 Jul, 2018 | Return|

On July 6, 2018 the FDA released an industry guidance document for transitioning from individual to pooled ZIKV testing. Additionally, on July 5th Grifols received licensure for their NAT ZIKV test for both individual and pooled donations.

Check out the Communication page for the complete details on the NAT ZIKV test or by clicking the link: Communications

Related

New Online Learning Center with New Content

The new online Learning Center with new content can still be found under the “Training” folder on ...

Read More >

Upcoming HCV Testing Algorithm Change

FDA Guidance titled “Further Testing of Donations that are Reactive on a Licensed Donor Screen...

Read More >

FDA Releases ZIKV Guidance and Grifols ZIKV Assay Licensed- 1st Update

This is the first update to the original CTS communication distributed on July 6th. As previously co...

Read More >

Reminder-Revised Client Forms

 Just a reminder that the revised client forms implement today! Don't forget to toss your o...

Read More >

FDA announces withdrawal of Guidance for ZIKV Testing

We are informing you that the FDA has announced their withdrawal of Guidance for ZIKV Testing. In th...

Read More >

COVID-19 Antibody Testing Frequently Asked Questions

The recent communication regarding the recent Anti-SARS-CoV-2 Total assay in Tampa has brought about...

Read More >